drugset / Trial / NCT00213278
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
Phase 2
Completed
50 enrolled
The Hospital for Sick Children
Ontario Cancer Research Network · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is examining whether Vinblastine is an effective drug to shrink low grade glioma brain tumors in children, and what the side effects are.
Timeline
- Start
- 2002-01
- Primary completion
- 2011-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vinblastine | Small molecule | 6 mg/m2 | Intravenous |